PRKN and breast carcinoma: Notably, an E3 ubiquitin ligase ARIH1 highly expressed in cancer cells could trigger mitophagy in a PINK1-dependent and Parkin-defective way; this countered the chemotherapy-induced cell death in breast cancer and lung adenocarcinomas, eventually resulting in cancer cell resistance (Villa et al., 2017).